Sign in Sign up for free

Last updated: 24 February 2022 at 9:00pm EST

Gary Balkema Net Worth




The estimated Net Worth of Gary S. Balkema is at least $1.34 Million dollars as of 22 February 2021. Mr. Balkema owns over 4,250 units of Brady stock worth over $1,129,168 and over the last 14 years he sold BRC stock worth over $0. In addition, he makes $208,026 as Independent Director at Brady.

Mr. Balkema BRC stock SEC Form 4 insiders trading

Gary has made over 2 trades of the Brady stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 4,250 units of BRC stock worth $114,750 on 22 February 2021.

The largest trade he's ever made was exercising 18,400 units of Brady stock on 26 February 2020 worth over $527,896. On average, Gary trades about 755 units every 12 days since 2010. As of 22 February 2021 he still owns at least 15,564 units of Brady stock.

You can see the complete history of Mr. Balkema stock trades at the bottom of the page.





Gary Balkema biography

Gary S. Balkema serves as Independent Director of the Company. He serves as the Chair of the Management Development and Compensation Committee and is a member of the Audit Committee. From 2000 to 2011, he served as the President of Bayer Healthcare LLC and Worldwide Consumer Care Division. He was also responsible for overseeing Bayer LLC USA's compliance program. He has over 20 years of general management experience. Mr. Balkema has served as a director of PLx Pharma, Inc. since 2016. and a master of business administration degree from Fairleigh Dickinson University. Mr. Balkema brings strong experience in consumer marketing skills and mergers, acquisitions and integrations. His broad operating and functional experience are valuable to the Company given the diverse nature of the Company's portfolio.

What is the salary of Gary Balkema?

As the Independent Director of Brady, the total compensation of Gary Balkema at Brady is $208,026. There are 14 executives at Brady getting paid more, with J. Michael Nauman having the highest compensation of $5,240,930.



How old is Gary Balkema?

Gary Balkema is 65, he's been the Independent Director of Brady since 2010. There are 3 older and 21 younger executives at Brady. The oldest executive at Brady Corp. is Frank Harris, 78, who is the Independent Director.

What's Gary Balkema's mailing address?

Gary's mailing address filed with the SEC is 9 FISHERS LANE, SUITE E, SPARTA, NJ, 07871.

Insiders trading at Brady

Over the last 24 years, insiders at Brady have traded over $114,775,257 worth of Brady stock and bought 44,600 units worth $1,303,074 . The most active insiders traders include Elizabeth P Bruno, Patrick W Allender, and Thomas J Felmer. On average, Brady executives and independent directors trade stock every 20 days with the average trade being worth of $1,110,450. The most recent stock trade was executed by Patrick W Allender on 23 May 2024, trading 4,250 units of BRC stock currently worth $96,305.



What does Brady do?

brady corporation is an international manufacturer and marketer of complete solutions that identify and protect premises, products and people. brady's products help customers increase safety, security, productivity and performance and include high-performance labels and signs, safety devices, printing systems and software, and precision die-cut materials. founded in 1914, the company has millions of customers in electronics, telecommunications, manufacturing, electrical, construction, education, medical and a variety of other industries. brady is headquartered in milwaukee, wisconsin and employs approximately 6,500 people at operations in the americas, europe and asia-pacific. brady's fiscal 2015 sales were approximately $1.17 billion. brady stock trades on the new york stock exchange under the symbol brc. brady's mission is to identify and protect premises, products and people. brady's vision is to be the market leader in all our businesses in order to achieve sustainable long-term



What does Brady's logo look like?

Brady Corp. logo

Complete history of Mr. Balkema stock trades at Brady and PLx Pharma

Date
#
Company
 Insider
Trans.
Transaction
 Shares Price per share Total value Shares after Source
22 Feb 2021 BRC Brady Corp. Gary S. Balkema
Director
 Option 4,250 $27.00 $114,750
22 Feb 2021
15,564 ↗
26 Feb 2020 BRC Brady Corp. Gary S. Balkema
Director
 Option 18,400 $28.69 $527,896
26 Feb 2020
16,192 ↗


Brady executives and stock owners

Brady executives and other stock owners filed with the SEC include: